Impact of Cholinergic Pathway Damage on Cognitive Impairment Caused by Cerebral White Matter Lesions

  • WANG Shi-nan ,
  • JIA Wei-li ,
  • FENG Li ,
  • CHEN Hong-yan ,
  • SHI Qing-li ,
  • LI Yue-xiu ,
  • ZHANG Yu-mei
Expand
  • 1. Department of Neurology, Beijing Tiantan Hosptial, Capital Medical University, Beijing 100050, China;
    2. Department of Neurology, Hebei Yanda Hosptial, Langfang, Hebei 065201, China

Received date: 2017-11-20

  Revised date: 2018-02-11

  Online published: 2018-03-27

Supported by

Supported by National Natural Science Foundation of China (No. 81371201), Capital Medical University Basic and Clinical Medical Cooperation Project (Key) (No. 16JL03) and Beijing Municipal Administration of Hospitals Special Funding for Clinical Medicine Development (No. ZYLX201836)

Abstract

Objective To investigate the relationship between cholinergic pathway damage and the executive dysfunction of patients with different degrees of cognitive impairment caused by cerebral white matter lesions (WML). Methods From March, 2016 to December, 2017, 115 patients were recruited, whose characteristics, such as age, gender, education, and history of hypertension, diabetes and stroke were recorded. According to the T2-weighted MRI, 80 patients were defined as WML. WML patients were divided into cognitively normal (CN) group (n=41), vascular cognitive impairment of none dementia (VCIND) group (n=21) and vascular dementia (VaD) group (n=18) according to the result of Montreal Cognitive Assessment (MoCA) and Clinical Dementia Rating (CDR). Other 35 cases without WML and cognitive impairment were as control group. WML under MRI were evaluated with Cholinergic Pathways Hyperintensities Scale (CHIPS). All the WML patients were assessed with Stroop Color-Word Test, Trail Making Test, Symbol Digital Modalities Test, and Verbal Fluence Test. The correlation between the scores of CHIPS and the executive tests were analysed. Results There was no significant difference in age, gender, level of education, and cardiovascular disease risk factors among four groups (P>0.05), but there were significant differences in scores of MoCA and CHIPS (F>25.781, P<0.001), while the score of MoCA was the least (P<0.01) and the scores of CHIPS were the most in VaD group (P<0.001). The CHIPS scores of left and bilateral hemisphere negatively correlated with all the scores of executive tests (P<0.05), while that of the right hemisphere just correlated with the scores of some executive tests (P<0.05).Conclusion For cognitive impairment after WML, cholinergic pathway damage may relate with the executive function impairment, especially the damage in left cerebral hemisphere.

Cite this article

WANG Shi-nan , JIA Wei-li , FENG Li , CHEN Hong-yan , SHI Qing-li , LI Yue-xiu , ZHANG Yu-mei . Impact of Cholinergic Pathway Damage on Cognitive Impairment Caused by Cerebral White Matter Lesions[J]. Chinese Journal of Rehabilitation Theory and Practice, 2018 , 24(3) : 313 -318 . DOI: 10.3969/j.issn.1006-9771.2018.03.013

References

[1] Dey AK, Stamenova V, Turner G, et al.Pathoconnectomics of cognitive impairment in small vessel disease: a systematic review[J]. Alzheimers Dement, 2016, 12(7): 831-845.
[2] Kim SH, Kang HS, Kim HJ, et al.The effect of ischemic cholinergic damage on cognition in patients with subcortical vascular cognitive impairment[J]. J Geriatr Psychiatry Neurol, 2012, 25(2): 122-127.
[3] Kim HJ, Moon WJ, Han SH.Differential cholinergic pathway involvement in Alzheimer's disease and subcortical ischemic vascular dementia[J]. J Alzheimers Dis, 2013, 35(1): 129-136.
[4] Park HE, Park IS, Oh YS, et al.Subcortical whiter matter hyperintensities within the cholinergic pathways of patients with dementia and parkinsonism[J]. J Neurol Sci, 2015, 353(1-2): 44-48.
[5] Bioti C, Swartz RH, Gao FQ, et al.A new visual rating scale to assess strategic white matter hyperintensities within cholinergic pathway in dementia[J]. Stroke, 2005, 36: 2126-2131.
[6] Jang YK, Kwon H, Kim YJ, et al.Early- vs late-onset subcortical vascular cognitive impairment[J]. Neurology, 2016, 86(6): 527-534.
[7] 何欣. 脑白质疏松症伴轻度认知障碍患者的认知障碍特点分析[J]. 航空航天医学杂志, 2016, 27(4): 441-443.
[8] Wardlaw JM, Smith EE, Biessels GJ, et al.Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration[J]. Lancet Neurol, 2013, 12(8): 822-838.
[9] Knopman DS, Griswold ME, Lirette ST, et al.Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study[J]. Stroke, 2015, 46(2): 433-440.
[10] Kaffashian S, Dugravot A, Elbaz A, et al.Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores[J]. Neurology, 2013, 80(14): 1300-1306.
[11] Chubykin AA, Roach EB, Bear MF, et al.A cholinergic mechanism for reward timing within primary visual cortex[J]. Neuron, 2013, 77(4): 723-735.
[12] Kimura Y, Sato N, Ota M, et al.A structural MRI study of cholinergic pathways and cognition in multiple sclerosis[J]. eNeurologicalSci, 2017, 8: 11-16.
[13] Foster-Dingley JC, Hafkemeijer A, van den Berg-Huysmans AA, et al. Structural covariance networks and their association with age, features of cerebral small-vessel disease, and cognitive functioning in older persons[J]. Brain Connect, 2016, 6(9): 681-690.
[14] Jiang H, Wei Y, Shi Y, et al.Altered macular microvasculature in mild cognitive impairment and alzheimer disease[J]. J Neuroophthalmol, 2017. doi: 10.1097/WNO.0000000000000580.[Epub ahead of print].
[15] Li R, Lai Y, Zhang Y, et al.Classification of cognitive level of patients with leukoaraiosis on the basis of linear and non-linear functional connectivity[J]. Front Neurol, 2017, 8: 2.
[16] 胡蓉,潘小平,杨淞然,等. 急性缺血性卒中抑郁-执行功能障碍综合征与胆碱能通路白质病变的关系研究[J]. 中国卒中杂志, 2015, 10(9): 735-739.
[17] Chen Y, Yan H, Han ZZ, et al.Functional activity connectivity diefferences of five resting-state networks in patients with Alzheimers or mild cognitive impairment[J]. Curr Alzheimer Res, 2016, 13: 234-242.
[18] Zhang T, Chen L, Wang Y, et al.Impaired theory of mind in Chinese children and adolescents with idiopathic generalized epilepsy: Association with behavioral manifestations of executive dysfunction[J]. Epilepsy Behav, 2018, 79: 205-212.
[19] Richter N, Beckers N, Onur OA, et al.Effect of cholinergic treatment depends on cholinergic integrity in early Alzheimer's disease[J]. Brain, 2018. doi: 10.1093/brain/awx356.[Epub ahead of print].
[20] Mito R, Raffelt D, Dhollander T, et al.Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment[J]. Brain, 2018. doi: 10.1093/brain/awx355.[Epub ahead of print].
[21] Ten Harmsen BL, van Rumund A, Aerts MB, et al. Clinical correlates of cerebral white matter abnormalities in patients with Parkinson's disease[J]. Parkinsonism Relat Disord, 2017. doi: 10.1016/j.parkreldis.2017.12.029.[Epub ahead of print].
[22] Della-Morte D, Dong C, Markert MS, et al.Carotid intima-media thickness is associated with white matter hyperintensities: the Northern Manhattan Study[J]. Stroke, 2018, 49(2): 304-311.
[23] Hirsiger S, Koppelmans V, Mérillat S, et al.Executive functions in healthy older adults are differentially related to macro- and microstructural white matter characteristics of the cerebral lobes[J]. Front Aging Neurosci, 2017, 9: 373.
Outlines

/